NewsWhore
04-23-2009, 04:10 AM
<img alt="" height="1" width="1">
Novartis First-Quarter Net Drops on Dollar's Strength (http://news.google.com/news/url?sa=T&ct=us/3-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601085%26sid%3DaMOaICEOFB48%26refer%3Deurope&cid=1339471739&ei=JRbwSZrxHuCpmQfckOWHBw&usg=AFQjCNHD5Hfvcg_JGS-7zvJMvGGU6Pa1HA)
Bloomberg
The company aims to “again deliver record underlying net sales and earnings excluding currency effects,” Vasella said in the statement. Sales at the drug unit rose 3 percent to $6.43 billion, driven by higher Gleevec and Diovan sales. ...
More... (http://news.google.com/news/url?sa=T&ct=us/3-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601085%26sid%3DaMOaICEOFB48%26refer%3Deurope&cid=1339471739&ei=JRbwSZrxHuCpmQfckOWHBw&usg=AFQjCNHD5Hfvcg_JGS-7zvJMvGGU6Pa1HA)
Novartis First-Quarter Net Drops on Dollar's Strength (http://news.google.com/news/url?sa=T&ct=us/3-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601085%26sid%3DaMOaICEOFB48%26refer%3Deurope&cid=1339471739&ei=JRbwSZrxHuCpmQfckOWHBw&usg=AFQjCNHD5Hfvcg_JGS-7zvJMvGGU6Pa1HA)
Bloomberg
The company aims to “again deliver record underlying net sales and earnings excluding currency effects,” Vasella said in the statement. Sales at the drug unit rose 3 percent to $6.43 billion, driven by higher Gleevec and Diovan sales. ...
More... (http://news.google.com/news/url?sa=T&ct=us/3-0&fd=R&url=http://www.bloomberg.com/apps/news%3Fpid%3D20601085%26sid%3DaMOaICEOFB48%26refer%3Deurope&cid=1339471739&ei=JRbwSZrxHuCpmQfckOWHBw&usg=AFQjCNHD5Hfvcg_JGS-7zvJMvGGU6Pa1HA)